Asystematic review of the OXT system in patients with CP, a condition at high risk ofdeveloping AVP-Deficiency (78),identified only two case reports describing long-term low-dose intranasal OXTadministration and one pilot study assessing the acute effects of a single OXT doseon emotion recognition (66,67,151,152). Here, AVP is linked to hyperinsulinemic hypoglycemia, familial, 4.